Cetuximab in the Context of Current Treatment of Squamous Cell Carcinoma of the Anus

J Clin Oncol. 2017 Mar;35(7):699-701. doi: 10.1200/JCO.2016.70.9394. Epub 2017 Jan 9.

Authors

Rob Glynne-Jones¹, Mark Harrison¹

Affiliation

¹ Rob Glynne-Jones and Mark Harrison, Centre for Cancer Treatment, Mount Vernon Hospital, Northwood, United Kingdom.

PMID: 28068173
DOI: 10.1200/JCO.2016.70.9394

No abstract available

Publication types

Editorial

MeSH terms

Antineoplastic Agents, Immunological / adverse effects
Antineoplastic Agents, Immunological / therapeutic use*
Anus Neoplasms / mortality
Anus Neoplasms / pathology
Anus Neoplasms / therapy*
Carcinoma, Squamous Cell / mortality
Carcinoma, Squamous Cell / pathology
Carcinoma, Squamous Cell / therapy*
Cetuximab / adverse effects
Cetuximab / therapeutic use*
Chemoradiotherapy / adverse effects
Chemoradiotherapy / methods*
Chemoradiotherapy / mortality
Clinical Trials as Topic
Female
Humans
Male
Middle Aged
Radiotherapy Dosage
Treatment Outcome

Substances

Antineoplastic Agents, Immunological
Cetuximab